BARCLAYS PLC - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66
-52.2%
17,777
-13.1%
0.00%
Q2 2023$138
-40.5%
20,460
-42.8%
0.00%
Q1 2023$232
+31.1%
35,782
+71.9%
0.00%
Q4 2022$177
-99.8%
20,810
+4.1%
0.00%
Q3 2022$106,000
+19.1%
19,985
-4.4%
0.00%
Q2 2022$89,000
+48.3%
20,897
+22.2%
0.00%
Q1 2022$60,00017,1050.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders